+91-22-40012000
companysecretary@marksanspharma.com
About
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
R&D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Manufacturing Facilities
Markets
Sample Product Portfolio
Health & Wellness
Consumer Self-Care Products
- OTC
Pain Management
Arthritis
Upper Respiratory
Cough & Cold
Allergy
Digestive Health
VMS
(Vitamins Minerals and Supplements)
Vitamins
Skin Care Products
Hair fall
Prescription
– Rx Therapeutic Segments
Cardiovascular System (CVS)
Central Nervous System (CNS)
Oncology
Anti-Diabetics
Anti-Biotic
R&D
Investor
General Information & Investor Contact
General Information
Composition of Board & Committees
Investor Contact
Materiality of Information
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
Shares Liable for Transfer to IEPF
Information for Shareholders
CSR Activities
Others Disclosures
Forms
Newspaper Advertisement
Related Party Transaction
Press Release
ESG Profile
Responsibility
CSR
Sustainability
Media
News
Photo / Video Gallery
Adverse Event
Careers
Overview
Values
Life at Marksans
Apply Now
Contact
General Information & Investor Contact
General Information
Composition of Board & Committees
Investor Contact
Materiality of Information
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
Shares Liable for Transfer to IEPF
Information for Shareholders
CSR Activities
Others Disclosures
Forms
Newspaper Advertisement
Related Party Transaction
Press Release
ESG Profile
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Investor Relations
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Earnings Call Transcripts
Home
Investor Relations
Financial Results
Quarterly Results
Quarterly Results
2014
Review Report 2014
December 2014
June 2014
September 2014
2013
March 2013
June 2013
September 2013
Standalone Results
Consolidate Results
December 2013
Standalone Results
Consolidate Results
2012
March 2012
June 2012
September 2012
December 2012
2011
March 2011
June 2011
September 2011
2010
March 2010
2009
June 2009
September 2009
December 2009
2008
June 2008
2007
March 2007
June 2007
September 2007
December 2007
2006
March 2006
June 2006
September 2006
December 2006
2005
September 2005
December 2005
